Journal of Clinical Endocrinology & Metabolism, Vol 81, 1471-1475, Copyright © 1996 by Endocrine Society

ARTICLES

Measurement of circulating inhibin forms during the establishment of pregnancy

PJ Illingworth, NP Groome, WC Duncan, V Grant, S Tovanabutra, DT Baird and AS McNeilly
Medical Research Council Reproductive Biology Unit, University of Edinburgh, United Kingdom. p.illingworth@ed-rbu.mrc.ac.uk.

This study investigated the forms of inhibin released into the circulation 1) in very early pregnancy, 2) after stimulation of the corpus luteum by exogenous hCG, and 3) in abnormal and failing human pregnancy. Samples were assayed by enzyme-linked immunosorbent assays for inhibin A, inhibin B, and inhibin pro-alphaC-related immunoreactivity (pro-alphaC-RI). The concentration of inhibin A rose steadily during the conception luteal phase to an initial peak 12 days after ovulation (104 +/- 23 pg/mL), then rose rapidly to a further peak 43 days after ovulation 424 +/- 6 pg/mL). The concentration of pro- alphaC-RI exhibited a much larger peak on day 15 after ovulation (1423 +/- 361 pg/mL), but fell thereafter. The concentration of inhibin B was low after ovulation and subsequently barely detectable in pregnancy. hCG treatment resulted in a significant rise in the concentrations of inhibin A and pro-alphaC-RI, but had no effect on the inhibin B concentration. The pro-alphaC-RI concentration was a better indicator of continuing pregnancy viability than either hCG or inhibin A. Early trophoblast secretes proportionately more bioactive inhibin than the corpus luteum. The corpus luteum and trophoblast do not secrete inhibin B into the circulation. These data support the concept of different physiological roles for different inhibin forms.

This article has been cited by other articles:

				J. Cartwright, W C. Duncan, H. O D Critchley, and A. W Horne Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities Reproduction, July 1, 2009; 138(1): 9 - 22. [Abstract] [Full Text] [PDF]

				M. Myers, S. van den Driesche, A. S McNeilly, and W C. Duncan Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin in vitro J. Endocrinol., November 1, 2008; 199(2): 201 - 212. [Abstract] [Full Text] [PDF]

				A. W. Horne, S. van den Driesche, A. E. King, S. Burgess, M. Myers, H. Ludlow, P. Lourenco, P. Ghazal, A. R. Williams, H. O. D. Critchley, et al. Endometrial Inhibin/Activin {beta}-B Subunit Expression Is Related to Decidualization and Is Reduced in Tubal Ectopic Pregnancy J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2375 - 2382. [Abstract] [Full Text] [PDF]

				G. R Hutchison, H. M Scott, M. Walker, C. McKinnell, D. Ferrara, I. K. Mahood, and R. M Sharpe Sertoli Cell Development and Function in an Animal Model of Testicular Dysgenesis Syndrome Biol Reprod, February 1, 2008; 78(2): 352 - 360. [Abstract] [Full Text] [PDF]

				M. Myers, E. Gay, A. S. McNeilly, H. M. Fraser, and W. C. Duncan In Vitro Evidence Suggests Activin-A May Promote Tissue Remodeling Associated with Human Luteolysis Endocrinology, August 1, 2007; 148(8): 3730 - 3739. [Abstract] [Full Text] [PDF]

				S. Tong, L. Rombauts, J. Onwude, B. Marjono, and E.M. Wallace Highly specific and sensitive rise in Days 14 17 pro-{alpha}C inhibin with clinical pregnancy after frozen embryo transfer with ovulatory cycles Hum. Reprod., August 1, 2007; 22(8): 2249 - 2253. [Abstract] [Full Text] [PDF]

				S. Tong, L. Rombauts, A. Mulder, B. Marjono, J. L. Onwude, and E. M. Wallace Increased Day 15-17 Serum Pro-{alpha}C Inhibin Levels Specific to Successful Pregnancy J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4464 - 4468. [Abstract] [Full Text] [PDF]

				S. Lahiri, C.J. Anobile, P. Stewart, and W.L. Ledger Changes in circulating concentrations of inhibins A and pro-{alpha} C during first trimester medical termination of pregnancy Hum. Reprod., April 1, 2003; 18(4): 744 - 748. [Abstract] [Full Text] [PDF]

				P. Y.K. Yong, D. T. Baird, K.J. Thong, A. S. McNeilly, and R. A. Anderson Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation Hum. Reprod., January 1, 2003; 18(1): 35 - 44. [Abstract] [Full Text] [PDF]

				C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF]

				P. Thirunavukarasu, T. Stephenson, J. Forray, P. G. Stanton, N. Groome, E. Wallace, and D. M. Robertson Changes in Molecular Weight Forms of Inhibin A and Pro-{alpha}C in Maternal Serum during Human Pregnancy J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5794 - 5804. [Abstract] [Full Text] [PDF]

				M. Creus, J. Ordi, F. Fabregues, R. Casamitjana, J. A. Vanrell, and J. Balasch Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation Hum. Reprod., July 1, 2001; 16(7): 1347 - 1352. [Abstract] [Full Text] [PDF]

				C. Treetampinich, A. E. O'Connor, V. MacLachlan, N. P. Groome, and D. M. de Kretser Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome Hum. Reprod., September 1, 2000; 15(9): 2028 - 2032. [Abstract] [Full Text] [PDF]

				F. Debieve, S. Pampfer, and K. Thomas Inhibin and activin production and subunit expression in human placental cells cultured in vitro Mol. Hum. Reprod., August 1, 2000; 6(8): 743 - 749. [Abstract] [Full Text] [PDF]

				S. C. Riley, R. Leask, C. Balfour, J. E. Brennand, and N. P. Groome Production of inhibin forms by the fetal membranes, decidua, placenta and fetus at parturition Hum. Reprod., March 1, 2000; 15(3): 578 - 583. [Abstract] [Full Text] [PDF]

				N. Lahlou, N. Chabbert-Buffet, S. Christin-Maitre, E. Le Nestour, M. Roger, and P. Bouchard Main inhibitor of follicle stimulating hormone in the luteal–follicular transition: inhibin A, oestradiol, or inhibin B? Hum. Reprod., May 1, 1999; 14(5): 1190 - 1193. [Abstract] [Full Text] [PDF]

				W. Byrd, M. J. Bennett, B. R. Carr, Y. Dong, F. Wians, and W. Rainey Regulation of Biologically Active Dimeric Inhibin A and B From Infancy to Adulthood in the Male J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2849 - 2854. [Abstract] [Full Text]

				F. Petraglia, S. Luisi, C. Benedetto, M. Zonca, P. Florio, E. Casarosa, A. Volpe, S. Bernasconi, and A. R. Genazzani Changes of Dimeric Inhibin B Levels in Maternal Serum Throughout Healthy Gestation and in Women with Gestational Diseases J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2991 - 2995. [Abstract] [Full Text] [PDF]

				P. Pigny, R. Desailloud, C. Cortet-Rudelli, A. Duhamel, D. Deroubaix-Allard, A. Racadot, and D. Dewailly Serum {alpha}-Inhibin Levels in Polycystic Ovary Syndrome: Relationship to the Serum Androstenedione Level J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1939 - 1943. [Abstract] [Full Text] [PDF]

				M. Birdsall, W. Ledger, N. Groome, H. Abdalla, and S. Muttukrishna Inhibin A and Activin A in the First Trimester of Human Pregnancy J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1557 - 1560. [Abstract] [Full Text] [PDF]

				E. M. Wallace, S. C. Riley, J. A. Crossley, S. C. Ritoe, A. Horne, M. Shade, P. M. Ellis, D. A. Aitken, and N. P. Groome Dimeric Inhibins in Amniotic Fluid, Maternal Serum, and Fetal Serum in Human Pregnancy J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 218 - 222. [Abstract] [Full Text] [PDF]